Anti-Herpes Simplex I [Clone HP1.3]
Referência 15201-500
Tamanho : 500ug
Marca : Leinco Technologies
Contactar o distribuidor local :
Telefone : +1 850 650 7790
AntiHerpes Simplex I [Clone HP1.3]
AntiHerpes Simplex I [Clone HP1.3]
Product No.: 15201
Clone HP1.3 Target Herpes simplex I Formats AvailableView All Product Type Monoclonal Isotype Mouse IgG2a Applications ELISA , IF |
Antibody DetailsProduct DetailsReactive Species Herpes Simplex 1 Host Species Mouse Immunogen HSV1 infected cells. Product Concentration Lot Specific Formulation This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 7.4 with no carrier protein or preservatives added. State of Matter Liquid Product Preparation Antibodies are purified by a multistep process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling This antibody is stable for at least one (1) year at 20°C to 70°C. Store product in appropriate aliquots to avoid multiple freezethaw cycles. Country of Origin USA Shipping Next Day 28°C Applications and Recommended Usage? Quality Tested by Leinco These antibodies have been qualified for use in ELISA and immunofluorescence to detect HSV I or II. End users should determine optimal concentrations for their applications. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Mouse Monoclonal Antibody specific to Herpes Simplex I (HSV I gD) Background Herpes simplex viruses are ubiquitous, hostadapted pathogens that cause a wide variety of infections. Two types exist: herpes simplex virus type 1 (HSV1) and type 2 (HSV2). Both are closely related but differ in epidemiology. HSV1 is traditionally associated with orofacial disease, while HSV2 is traditionally associated with genital disease. Up to 80% of herpes simplex infections are asymptomatic. Symptomatic infections can be characterized by significant morbidity and recurrence. In immunocompromised hosts, infections can cause lifethreatening complications. Research Area Infectious Disease References & Citations |